Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- RefSeek
- Hamdard University
- EBSCO A-Z
- SWB online catalog
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Advances in Pharmacoepidemiology and Drug Safety have been cited by esteemed scholars and scientists all around the world. Advances in Pharmacoepidemiology and Drug Safety has got h-index 11, which means every article in Advances in Pharmacoepidemiology and Drug Safety has got 11 average citations.
Following are the list of articles that have cited the articles published in Advances in Pharmacoepidemiology and Drug Safety.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
20 | 56 | 30 | 32 | 23 | 3 | 4 | 7 | 22 | 38 | 32 | 27 | 49 |
Research, Review articles and Editorials |
0 | 1 | 1 | 21 | 15 | 3 | 3 | 3 | 14 | 20 | 24 | 17 | 28 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 55 | 31 | 11 | 8 | 0 | 1 | 4 | 8 | 18 | 8 | 10 | 21 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
43 | 62 | 72 | 97 | 66 | 85 | 68 | 49 | 101 | 34 | 21 | 13 | 0 |
| Journal total citations count | 553 |
| Journal impact factor | 2.86 |
| Journal 5 years impact factor | 4.33 |
| Journal cite score | 5.34 |
| Journal h-index | 11 |
Important citations
Schooley B, Godwin A, Vemula J, Ausdenmoore HC, Sartor O, Yang YT, Armitage JO, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR. Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
Alomi YA, Al-Jarallah SM. The cost analysis of network drug information services at ministry of health institutions in Saudi Arabia. J Pharm Pract Community Med. 2018;4(4):226-30.
Alomi YA, El-Bahnasawi M, Elemam A, Shaweesh T, Antonio EJ. The economic outcomes of pharmacist interventions at critical care services of private hospital in Riyadh City, Saudi Arabia. Pharmacology, Toxicology and Biomedical Reports. 2019;5(3s).
Bennett CL, Schoen MW, Hoque S, Witherspoon BJ, Aboulafia DM, Hwang CS, Ray P, Yarnold PR, Chen BK, Schooley B, Taylor MA. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. The Lancet Oncology. 2020 Dec 1;21(12):e575-88.
Alomi YA, Almudaiheem HY. Cost efficiency of national drug information center services through ministry of health hotline calling center (937) in Saudi Arabia. International Journal of Pharmacy and Health Sciences. 2019;2(1).
Alomi YA, Aldosary BA. Cost analysis of activities for network drug information centers at the ministry of health hospitals in Saudi Arabia. International Journal of Pharmacy and Health Sciences. 2019;2(1).
Alomi YA, Zahran R. Self-Assessment of mass gathering (Hajj) pharmaceutical care program in Saudi Arabia. J Pharm Pract Community Med. 2016;2(24):137-43.
Bennett CL, Schooley B, Taylor MA, Witherspoon BJ, Godwin A, Vemula J, Ausdenmoore HC, Sartor O, Yang YT, Armitage JO, Hrushesky WJ. Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions. PloS one. 2019 Jul 31;14(7):e0219521.
Yang A, Baxi S, Korenstein D. ClinicalTrials. gov for facilitating rapid understanding of potential harms of new drugs: the case of checkpoint inhibitors. Journal of oncology practice. 2018 Feb;14(2):72.
Magwood-Golston JS, Kessler S, Bennett CL. Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry. Leukemia research. 2016 May 1;44:61-4.
Tuccori M, Montagnani S, Capogrosso-Sansone A, Mantarro S, Antonioli L, Fornai M, Blandizzi C. Adverse reactions to oncologic drugs: spontaneous reporting and signal detection. Expert review of clinical pharmacology. 2015 Jan 2;8(1):61-75.
Hussein HA, Maraie NK. Tenoxicam-loaded polymeric micelles material: Formulation, optimization, and evaluation. Materials Today: Proceedings. 2021 Sep 15.
Astorp J, Gjela M, Jensen P, Bak RD, Gazerani P. Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes. Future Science OA. 2020 May 29;6(8):FSO590.
Alomi YA, Alamoudi NH, Alanazi S, Almasoudi AH. Attitude and Perception of Physicians towards Adverse Drug Reaction Reporting in Saudi Arabia. International Journal of Pharmacology and Clinical Sciences. 2021;10(1).
Nurfitria RS, Effendi RN, Iskandar D. Potential Medication Errors in Electronic Prescribing in A Primary Health Care. Indonesian Journal of Pharmaceutical and Clinical Research. 2019 Aug 9;2(1):45-54.
Valent F. Polypharmacy in the general population of a Northern Italian area: analysis of administrative data. Annali dell'Istituto superiore di sanita. 2019 Sep 23;55(3):233-9.
Hayward S, Hole B, Denholm R, Duncan P, Morris JE, Fraser SD, Payne RA, Roderick P, Chesnaye NC, Wanner C, Drechsler C. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study. Nephrology Dialysis Transplantation. 2021 Mar;36(3):503-11.
Vrettos I, Voukelatou P, Katsoras A, Theotoka D, Kalliakmanis A. Diseases linked to polypharmacy in elderly patients. Current gerontology and geriatrics research. 2017 Dec 25;2017.
Slater N, White S, Venables R, Frisher M. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA). BMJ open. 2018 Mar 1;8(3):e020270.
Alomi YA, Alamoudi NH, Alanazi S, Almasoudi AH. Physician’s Practice of Adverse Drug Reaction in Saudi Arabia. International Journal of Pharmacology and Clinical Sciences. 2021;10(1).